According to the results of joint negotiations of UnifiedDistributor LLC “SK-Pharmacy” and “Glaxo Smith Kline” company, being one the largest pharmaceutical company in the world, new legal entity was created LLC “Glaxo Smith Kline Kazakhstan”.

LLC “SK-Pharmacy” put on record about conclusion of memorandum on cooperation in the field of medicine provision of Kazakhstan population with new formed affiliate. Asoneofstrategicaltasksinthedevelopmentplanof “SK-Pharmacy”for the closest time is establishment of relationships directly with foreign manufacturers of medicines not having the registered analogues in Republic of Kazakhstan, this memorandum is one of significant steps forward to the set goals achievement.

Management of LLC "SK-Pharmacy" notes that the business transformation "Glaxo Smith Kline" in Kazakhstan is timely and the creation of Kazakhstan legal entity LLC Glaxo Smith Klein Kazakhstan” will give a new impetus to bilateral cooperation in the framework of signed Memorandum and effectively implement the National medicines policy.

Direct cooperation with such a major player in the pharmaceutical market will allow, firstly, concluding direct contracts on products without analogues and making payments in the national currency, and secondly, participating in tender procedures directly, thirdly, it forms an effective communications platform in the country; fourthly, creating favorable taxation scheme for foreign manufacturers.

"We Express our willingness and openness in the development of partnership relations and hope to continue a constructive dialogue!"- concluded the Chairman of the Board Alibayev N. N.